Tani Hideaki 谷英明

Researcher Number	30570907
Other IDs
Affiliation (Current)	2026: 慶應義塾大学, 医学部(信濃町), 講師
Affiliation (based on the past Project Information) *help	2024 – 2025: 慶應義塾大学, 医学部(信濃町), 講師 2023: 慶應義塾大学, 医学部(信濃町), 専任講師 2022 – 2023: 慶應義塾大学, 医学部(信濃町), 助教
Review Section/Research Field	Principal Investigator Basic Section 52030:Psychiatry-related Except Principal Investigator Basic Section 52030:Psychiatry-related
Keywords	Principal Investigator 治療抵抗性うつ病 / 神経可塑性 / 主観的体験 / ケタミン / MRI / PET / AMPA受容体 Except Principal Investigator グルタミン酸 / 薬物療法 / グルタミン酸神経系 / ケタミン / AMPA受容体 / うつ病

ケタミン投与による主観的体験がもたらす抗うつ効果の心理学的・生物学的基盤の解明Principal Investigator
- Principal Investigator
  
  谷英明
- Project Period (FY)
  2025 – 2027
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 52030:Psychiatry-related
- Research Institution
  Keio University
38.Elucidating mechanisms of antidepressant effects of ketamine for treatment-resistant depression: an AMPA PET study
- Principal Investigator
  
  Uchida Hiroyuki
- Project Period (FY)
  2024
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 52030:Psychiatry-related
- Research Institution
  Keio University
新たな治療法の開発に向けた治療抵抗性うつ病の神経基盤の解明：AMPA-PET研究Principal Investigator
- Principal Investigator
  
  谷英明
- Project Period (FY)
  2022 – 2025
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 52030:Psychiatry-related
- Research Institution
  Keio University

All 2024 2023 2022

All Journal Article Presentation

[Journal Article] Characterization of patients with major psychiatric disorders with AMPA receptor positron emission tomography2024
- Author(s)
  Hatano Mai、（他23名）Takahashi Takuya
- Journal Title
  
  Molecular Psychiatry
  
  Volume: 30 Issue: 5 Pages: 1780-1790
- DOI
  10.1038/s41380-024-02785-1
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-ORGANIZER-20H05914, KAKENHI-PROJECT-23K21414, KAKENHI-PROJECT-23K24262, KAKENHI-PROJECT-23K24278, KAKENHI-PROJECT-23K24263, KAKENHI-PROJECT-24K02383, KAKENHI-PROJECT-24KJ0185, KAKENHI-PROJECT-20KK0193
[Journal Article] Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment‐resistant depression: A double‐blind, randomized, placebo‐controlled trial2024
- Author(s)
  Ohtani Yohei、Uchida Hiroyuki
- Journal Title
  
  Psychiatry and Clinical Neurosciences
  
  Volume: 78 Issue: 12 Pages: 765-775
- DOI
  10.1111/pcn.13734
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K24262, KAKENHI-PROJECT-23KJ1898, KAKENHI-PROJECT-23K24263, KAKENHI-PROJECT-20KK0193
[Journal Article] α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor density underlies intraregional and interregional functional centrality2024
- Author(s)
  Yatomi Taisuke、Tomasi Dardo、Tani Hideaki、Nakajima Shinichiro、Tsugawa Sakiko、Nagai Nobuhiro、Koizumi Teruki、Nakajima Waki、Hatano Mai、Uchida Hiroyuki、Takahashi Takuya
- Journal Title
  
  Frontiers in Neural Circuits
  
  Volume: 18 Pages: 1497897-1497897
- DOI
  10.3389/fncir.2024.1497897
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-ORGANIZER-20H05914, KAKENHI-PROJECT-23K24262, KAKENHI-PROJECT-23KJ1898, KAKENHI-PROJECT-23K24263, KAKENHI-PROJECT-20KK0193
[Journal Article] Factors Associated with Antidepressant Effects of Ketamine: A Reanalysis of Double-Blind Randomized Placebo-Controlled Trial of Intravenous Ketamine for Treatment-Resistant Depression2023
- Author(s)
  Yonezawa Kengo、Uchida Hiroyuki、Yatomi Taisuke、Ohtani Yohei、Nomoto-Takahashi Kie、Nakajima Shinichiro、Mimura Masaru、Tani Hideaki
- Journal Title
  
  Pharmacopsychiatry
  
  Volume: 57 Issue: 01 Pages: 35-40
- DOI
  10.1055/a-2179-8884
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K24262, KAKENHI-PROJECT-23K24263, KAKENHI-PROJECT-23KJ1898
[Journal Article] Predicting relapse from the time to remission during the acute treatment of depression: A re-analysis of the STAR*D data2023
- Author(s)
  Kubo Kaoruhiko、Sakurai Hitoshi、Tani Hideaki、Watanabe Koichiro、Mimura Masaru、Uchida Hiroyuki
- Journal Title
  
  Journal of Affective Disorders
  
  Volume: 320 Pages: 710-715
- DOI
  10.1016/j.jad.2022.09.162
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K15755, KAKENHI-PROJECT-23K24262
[Presentation] Positive Correlation between AMPA Receptor Density and Local and Global Functional Centrality: [11C]K-2 PET and Resting-State fMRI Study.2024
- Author(s)
  Yatomi T, Tomasi D, Tsugawa S, Tani H, Koizumi T, Nagai N, Nakajima S, Ohtani Y, Nomoto-Takahashi K, Nakajima W, Hatano M, Uchida H, Takahashi T.
- Organizer
  The 2024 Society of Biological Psychiatry, Austin
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K15793
[Presentation] Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment-resistant depression: A double-blind, randomized, placebo-controlled trial2024
- Author(s)
  Ohtani Y, Tani H, Nomoto-Takahashi K, Yatomi T, Yonezawa K, Tomiyama S, Nagai N, Kusudo K, Honda S, Nakajima S, Eiro T, Miyazaki T, Takahashi T, Uchida H
- Organizer
  35th World Congress Collegium Internationale Neuro-Psychopharmacologicum
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K24262
[Presentation] he association between hippocampal volume changes and depressive symptom improvements after repeated ketamine infusion in treatment-resistant depression.2024
- Author(s)
  Yonezawa K, Nakajima S, Hondo N, Ohtani Y, Nomoto-Takahashi K, Yatomi T, Honda S, Koike S, Uchida H, Tani H.
- Organizer
  37th ECNP Congress, Milan
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K15793
[Presentation] Quantitative Susceptibility Mapping and R2 Are Associated with Antidepressant Effects of Ketamine: A Double-blind, Randomized, Placebo-controlled Trial2024
- Author(s)
  Yonezawa K, Nakajima S, Shibukawa S, Ohtani Y, Nomoto-Takahashi K, Yatomi T, Tomiyama S, Nagai N, Kusudo K, Honda S, Koike S, Uchida H, Tani H
- Organizer
  35th World Congress Collegium Internationale Neuro-Psychopharmacologicum
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K24262
[Presentation] AMPA受容体密度は安静時ネットワークのハブ性を規定する2023
- Author(s)
  彌富泰佑，津川幸子，谷英明，小泉輝樹，長井信弘，中島振一郎，大谷洋平，野本（高橋）希衣，中島和希，波多野真依，内田裕之，高橋琢哉
- Organizer
  第63回日本核医学会学術総会
- Data Source
  KAKENHI-PROJECT-22K15793
[Presentation] ケタミンの抗うつ作用と関連する因子：治療抵抗性うつ病に対するケタミン静注の二重盲検プラセボ対照試験の再解析2022
- Author(s)
  米澤賢吾, 谷英明, 三村將, 内田裕之
- Organizer
  第32回日本臨床精神神経薬理学会年会
- Data Source
  KAKENHI-PROJECT-22K15793

1. Uchida Hiroyuki (40327630)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
2. 山田高成 (20348767)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
3. 中島振一郎 (60383866)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
4. 岩渕雄 (90573262)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. 高橋琢哉

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
6. 櫻井準

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Tani Hideaki 谷 英明

Research Projects

Research Products

Co-Researchers

ケタミン投与による主観的体験がもたらす抗うつ効果の心理学的・生物学的基盤の解明Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

38.Elucidating mechanisms of antidepressant effects of ketamine for treatment-resistant depression: an AMPA PET study

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

新たな治療法の開発に向けた治療抵抗性うつ病の神経基盤の解明：AMPA-PET研究Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Characterization of patients with major psychiatric disorders with AMPA receptor positron emission tomography2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment‐resistant depression: A double‐blind, randomized, placebo‐controlled trial2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor density underlies intraregional and interregional functional centrality2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Factors Associated with Antidepressant Effects of Ketamine: A Reanalysis of Double-Blind Randomized Placebo-Controlled Trial of Intravenous Ketamine for Treatment-Resistant Depression2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Predicting relapse from the time to remission during the acute treatment of depression: A re-analysis of the STAR*D data2023

Author(s)

Journal Title

DOI

Data Source

[Presentation] Positive Correlation between AMPA Receptor Density and Local and Global Functional Centrality: [11C]K-2 PET and Resting-State fMRI Study.2024

Author(s)

Organizer

Data Source

[Presentation] Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment-resistant depression: A double-blind, randomized, placebo-controlled trial2024

Author(s)

Organizer

Data Source

[Presentation] he association between hippocampal volume changes and depressive symptom improvements after repeated ketamine infusion in treatment-resistant depression.2024

Author(s)

Organizer

Data Source

[Presentation] Quantitative Susceptibility Mapping and R2 Are Associated with Antidepressant Effects of Ketamine: A Double-blind, Randomized, Placebo-controlled Trial2024

Author(s)

Organizer

Data Source

[Presentation] AMPA受容体密度は安静時ネットワークのハブ性を規定する2023

Author(s)

Organizer

Data Source

[Presentation] ケタミンの抗うつ作用と関連する因子：治療抵抗性うつ病に対するケタミン静注の二重盲検プラセボ対照試験の再解析2022

Author(s)

Organizer

Data Source

Tani Hideaki 谷英明